Clinical, medical and diagnostics
Amsbio, in partnership with Research Donors, has expanded access to fresh human whole blood products sourced from diverse, healthy donors, with next-day delivery now available across the US, UK and Europe.
The biospecimens are rigorously serology-screened and rapidly processed to preserve high viability, supporting a wide range of downstream applications in life science research. Each sample is supplied with detailed donor metadata, including age, sex, blood type and additional characteristics, alongside full consent and compliance documentation for use in areas such as biomarker discovery, genetic analysis and translational research.
The company also offers flexibility in sample configuration to support specific experimental requirements, including a choice of anticoagulants such as EDTA, heparin or citrate, as well as tailored collection formats and delivery options. This is particularly important for researchers working across PBMCs, plasma, serum, leukopaks, buffy coats, isolated immune cells and whole blood, where pre-analytical variables can significantly influence assay performance and data quality.
By enabling rapid access to high-quality, customisable human blood biospecimens, Amsbio aims to streamline sample sourcing and support progress in immunology, diagnostics, drug development and cell therapy research.
More information online
ILM Guide 2026/27